To touch on that is what we found is if we start with, again, a micro-dose and go slowly with the GLP-1s, the nausea is virtually unheard of
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases
Though much of the research around PDA and BPC-157 remains preliminary, studies and clinical observations suggest the following mechanisms: 1
BPC-157 promotes healing in various tissues, including muscles, tendons, ligaments, and the gastrointestinal tract
So, if I can keep myself which I believe I will, knock wood alive, Id love to act until I literally cant do it anymore
This dual mechanism produces synergistic insulin secretion and appetite suppression that neither pathway achieves alone, which is part of why the tirzepatide dosage chart in units matters so much when you are working at the lower end of the dose spectrum